Evidence map›Paper›PMID 35693741›Full record

ArticleInternational journal of medical sciences2022

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.

Yang Wang, Yanna Liu, Hao Liao, Zhongping Deng, Dandan Bian, Yan Ren, Guangxin Yu, Yingying Jiang, Li Bai, Shuang Liu and 7 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Functional Cure for Hepatitis B Virus: Challenges and Achievements.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. [A conceptual framework for dynamics of cccDNA in hepatitis B virus].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  8. Review
  9. Review
  10. [Progress on the research of liver diseases in 2022].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Yang WangLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Yanna LiuDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Hao LiaoDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Zhongping DengAcademy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Dandan BianLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Yan RenLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Guangxin YuDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Yingying JiangLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Li BaiLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Shuang LiuLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Mei LiuLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Li ZhouLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Yu ChenLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Xinyue ChenLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Zhongping DuanLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Fengmin LuDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Sujun ZhengLiver disease center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Peking University · CNBeijing YouAn Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis B, ChronicHepatitis B Surface AntigensAntiviral AgentsBiomarkersDNA, CircularDNA, ViralHepatitis B e AntigensHepatitis B virusHumansLiverPlant ExtractsRNAAntiviral AgentsBiomarkersDNA, CircularDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensnasPlant ExtractsRNAchronic hepatitis Bcovalently closed circular DNAhepatitis B surface antigennucleos(t)ide analoguespregenomic RNA

Identifiers

PMID35693741
PMCPMC9149645
OpenAlexW4285123187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.